BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 16275011)

  • 1. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
    Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
    J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case study of the effect of covariate adjustment in a sequential survival clinical trial.
    Todd S; Sahdra M
    J Biopharm Stat; 2001 Nov; 11(4):297-311. PubMed ID: 12018781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dealing with competing risks: testing covariates and calculating sample size.
    Pintilie M
    Stat Med; 2002 Nov; 21(22):3317-24. PubMed ID: 12407674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Power and sample size calculations for discrete bounded outcome scores.
    Tsonaka R; Rizopoulos D; Lesaffre E
    Stat Med; 2006 Dec; 25(24):4241-52. PubMed ID: 16947202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A note on non-parametric ANCOVA for covariate adjustment in randomized clinical trials.
    Lesaffre E; Senn S
    Stat Med; 2003 Dec; 22(23):3583-96. PubMed ID: 14652862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.
    Sullivan LM; D'Agostino RB
    Stat Med; 2003 Apr; 22(8):1317-34. PubMed ID: 12687657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test.
    Brookes ST; Whitely E; Egger M; Smith GD; Mulheran PA; Peters TJ
    J Clin Epidemiol; 2004 Mar; 57(3):229-36. PubMed ID: 15066682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjusting for partially missing baseline measurements in randomized trials.
    White IR; Thompson SG
    Stat Med; 2005 Apr; 24(7):993-1007. PubMed ID: 15570623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covariate adjustment in heart failure randomized controlled clinical trials: a case analysis of the HF-ACTION trial.
    O'Connor CM; Mentz RJ; Whellan DJ
    Heart Fail Clin; 2011 Oct; 7(4):497-500. PubMed ID: 21925432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covariate-based linkage analysis: application of a propensity score as the single covariate consistently improves power to detect linkage.
    Doan BQ; Sorant AJ; Frangakis CE; Bailey-Wilson JE; Shugart YY
    Eur J Hum Genet; 2006 Sep; 14(9):1018-26. PubMed ID: 16736037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Goodness-of-fit processes for logistic regression: simulation results.
    Hosmer DW; Hjort NL
    Stat Med; 2002 Sep; 21(18):2723-38. PubMed ID: 12228887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of continuous versus dichotomous outcome variables on study power when sample sizes of orthopaedic randomized trials are small.
    Bhandari M; Lochner H; Tornetta P
    Arch Orthop Trauma Surg; 2002 Mar; 122(2):96-8. PubMed ID: 11880910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power and money in cluster randomized trials: when is it worth measuring a covariate?
    Moerbeek M
    Stat Med; 2006 Aug; 25(15):2607-17. PubMed ID: 16217840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplicity-adjusted sample size requirements: a strategy to maintain statistical power with Bonferroni adjustments.
    Leon AC
    J Clin Psychiatry; 2004 Nov; 65(11):1511-4. PubMed ID: 15554764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals.
    Austin PC; Manca A; Zwarenstein M; Juurlink DN; Stanbrook MB
    J Clin Epidemiol; 2010 Feb; 63(2):142-53. PubMed ID: 19716262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.